
Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study
Shao, Shih-Chieh, Chang, Kai-Cheng, Hung, Ming-Jui, Yang, Ning-I, Chan, Yuk-Ying, Chen, Hui-Yu, Kao Yang, Yea-Huei, Lai, Edward Chia-ChengVolume:
18
Langue:
english
Journal:
Cardiovascular Diabetology
DOI:
10.1186/s12933-019-0919-9
Date:
December, 2019
Fichier:
PDF, 3.31 MB
english, 2019